What will ‘TrumpRx’ actually mean for patients? Who will benefit most from slashed drug costs — and what those savings will look like
PositiveU.S News

The recent report by the RAND Corporation highlights that prescription drug prices in the US are significantly higher than in other high-income countries, with costs being about 2.78 times greater on average. This disparity raises important questions about the implications of initiatives like 'TrumpRx', which aims to reduce these costs. Understanding who will benefit from these potential savings is crucial for patients and policymakers alike, as it could lead to more affordable healthcare options for millions.
— Curated by the World Pulse Now AI Editorial System